Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1982 1
1988 1
1989 1
1990 1
1992 2
1993 5
1994 5
1995 2
1996 4
1997 2
1998 5
1999 3
2002 2
2003 3
2004 4
2005 4
2006 5
2007 8
2008 15
2009 7
2010 4
2011 8
2012 5
2013 4
2014 2
2015 3
2016 4
2017 4
2018 4
2019 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

117 results
Results by year
Filters applied: . Clear all
Page 1
Phase 0 trials: a platform for drug development?
Lancet. 2009 Jul 18;374(9685):176. doi: 10.1016/S0140-6736(09)61309-X. Lancet. 2009. PMID: 19616703 No abstract available.
The exploratory IND.
Mills G. Mills G. J Nucl Med. 2008 Jun;49(6):45N-47N. J Nucl Med. 2008. PMID: 18511824 Free article. No abstract available.
Regulatory considerations for preclinical development of anticancer drugs.
DeGeorge JJ, Ahn CH, Andrews PA, Brower ME, Giorgio DW, Goheer MA, Lee-Ham DY, McGuinn WD, Schmidt W, Sun CJ, Tripathi SC. DeGeorge JJ, et al. Cancer Chemother Pharmacol. 1998;41(3):173-85. doi: 10.1007/s002800050726. Cancer Chemother Pharmacol. 1998. PMID: 9443633 Review.
117 results
Jump to page
Feedback